MedicarePartD.guide

A non-government resource built from CMS public data

RYALTRIS 665/25 ug Spray, Metered

Also known as Olopatadine Hydrochloride And Mometasone Furoate. Coverage in Wisconsin (CMS PDP Region 16).

3 of 10 stand-alone Part D plans in Wisconsin cover this drug on tier 3–4.

2 of 3 plans apply a prior authorization, step therapy or quantity limit.

29 Medicare Advantage plans in WI do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. WI: 29 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
AARP Medicare Rx Preferred from UHC (PDP)$113.90/mo premium · $130.00 deductible3Preferred Brand15%15%$8.3570—None
HealthSpring Assurance Rx (PDP)$0.00/mo premium · $615.00 deductible4Non-Preferred Drug30%30%$7.6648—
  • Step therapy
HealthSpring Extra Rx (PDP)$56.30/mo premium · $615.00 deductible4Non-Preferred Drug33%33%$7.6639—
  • Step therapy

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →